Annual Shareholders Equity
$117.85 M
-$72.12 M-37.96%
December 31, 2022
Summary
- As of February 8, 2025, AMAM annual stockholders equity is $117.85 million, with the most recent change of -$72.12 million (-37.96%) on December 31, 2022.
- During the last 3 years, AMAM annual shareholders equity has risen by +$84.43 million (+252.59%).
Performance
AMAM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$242.40 M
-$7.98 M-3.19%
September 1, 2023
Summary
- As of February 8, 2025, AMAM quarterly stockholders equity is $242.40 million, with the most recent change of -$7.98 million (-3.19%) on September 1, 2023.
Performance
AMAM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AMAM Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.0% | - |
| 3 y3 years | +252.6% | +273.9% |
| 5 y5 years | +252.6% | - |
AMAM Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.0% | at low | -3.2% | -51.4% |
| 5 y | 5-year | -38.0% | -218.3% | -3.2% | -157.5% |
| alltime | all time | -38.0% | -218.3% | -3.2% | -157.5% |
Ambrx Biopharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $242.40 M(-3.2%) |
| Jun 2023 | - | $250.38 M(+37.1%) |
| Mar 2023 | - | $182.59 M(+54.9%) |
| Dec 2022 | $117.85 M(-38.0%) | $117.85 M(-16.9%) |
| Jun 2022 | - | $141.89 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $189.97 M(-236.2%) | - |
| Dec 2021 | - | $189.97 M(-1.5%) |
| Jun 2021 | - | $192.80 M(-238.3%) |
| Dec 2020 | -$139.43 M(-517.2%) | - |
| Dec 2020 | - | -$139.43 M |
| Dec 2019 | $33.42 M | - |
FAQ
- What is Ambrx Biopharma annual stockholders equity?
- What is the all time high annual shareholders equity for Ambrx Biopharma?
- What is Ambrx Biopharma annual shareholders equity year-on-year change?
- What is Ambrx Biopharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Ambrx Biopharma?
What is Ambrx Biopharma annual stockholders equity?
The current annual shareholders equity of AMAM is $117.85 M
What is the all time high annual shareholders equity for Ambrx Biopharma?
Ambrx Biopharma all-time high annual stockholders equity is $189.97 M
What is Ambrx Biopharma annual shareholders equity year-on-year change?
Over the past year, AMAM annual stockholders equity has changed by -$72.12 M (-37.96%)
What is Ambrx Biopharma quarterly stockholders equity?
The current quarterly shareholders equity of AMAM is $242.40 M
What is the all time high quarterly shareholders equity for Ambrx Biopharma?
Ambrx Biopharma all-time high quarterly stockholders equity is $250.38 M